CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Pharmacore Biotech Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Pharmacore Biotech Co Ltd
No.2, Lane 31, Section 1, Huanxi Road
Xinshi District
Phone: +886 65057182p:+886 65057182 Tainan, 744  Taiwan, Republic of China Fax: +886 62216910f:+886 62216910
Business Summary
PharmaCore Biotech Co., Ltd. is a Taiwan-based company mainly engaged in the contract research, development and manufacture of pharmaceutical products Contract Development and Manufacture Organization (CDMO), the import agent of active pharmaceutical ingredients (API), and the process development, manufacture and sale of its own products, such as APIs and preparations. The Company mainly provides CDMO technical services and the import agent of APIs. The Company provides pharmaceutical products CDMO service. The Company provides contract development and manufacture services to various pharmaceutical companies in Taiwan, import agent service of APIs, as well as officially certified APIs to pharmaceutical companies in Taiwan. The Company’s new products and services under development include CDMO services, such as C301 related products, as well as its own products, such as Alprostadil frozen crystal injection, Heparin injection and anticancer injection products.
(Source: PROSPECTUS)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202012/31/2020Yes----

Industries
SIC Code Description
8731 Commercial physical and biological research
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board WeihongZeng 10/28/2020
General Manager, Director ShengGao 10/28/2020 8/28/2020
Head of Finance & Accounting LongzhangGuo 6/2/2020 7/2/2019
5 additional Officers and Directors records available in full report.

General Information
Outstanding Shares: 29,477,000 (As of 12/31/2020)
Stock Exchange: TPO
Fax Number: +886 62216910


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, December 31, 2023